Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 23, 2019
Patent Application Number
14800631
Date Filed
December 30, 2014
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.